Literature DB >> 21869605

Can prion disease suspicion be supported earlier? Clinical, radiological and laboratory findings in a series of cases.

Alejandra González-Duarte1, Zaira Medina, Rainier Rodriguez Balaguer, Jesus Higuera Calleja.   

Abstract

The subacute spongiform encephalopathies are prion diseases characterized by acute and rapid neurodegeneration that lead to the death of the patient within months to a few years. The epidemiology of CJD is complicated and the frequency in Mexico is unknown. We aim to describe the cases of prion disease in Mexico. Consecutive patients who met the diagnostic criteria by the WHO were enrolled. We describe 26 patients with clinical manifestations, imaging and laboratory studies compatible with prion disease. The mean age at onset was 52 years old. The main clinical manifestations were cognitive alterations (69%) followed by extrapyramidal movements (50%), abnormal cerebellar function (46%), behavioral alterations (46%), myoclonus (46%), and mood depression (23%), among other features. Half of the patients progressed rapidly to a state of akinetic mutism (53%). Only 2 (7.6%) patients had a family history of a similar disease. Time interval between onset and diagnosis varied between 71 days to 24 months, with a median of 6 months. The classical bilateral basal ganglia hyperintensities were present in the very early stage of the disease. Protein 14-3-3 immuneassay in the CSF was positive in all measured cases. Bilateral basal ganglia hyperintensities was the most important early finding, while protein 14-3-3 was a late finding and the results were usually obtained after the patient was discharged. Around 1.5 cases of CJD cases per year are reported in our country. When suspected, MRI can support the diagnosis earlier than other studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21869605      PMCID: PMC3226047          DOI: 10.4161/pri.5.3.16187

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  9 in total

Review 1.  [A case of Creutzfeldt-Jakob in the Mexican north-east and review of current concepts on prion disease].

Authors:  A L Calderón-Garcidueñas; J A Sagastegui-Rodríguez; C Canales-Ibarra; R Farías-García
Journal:  Gac Med Mex       Date:  2001 Nov-Dec       Impact factor: 0.302

2.  Advances in diagnosing Creutzfeldt-Jakob disease with MRI and CSF 14-3-3 protein analysis.

Authors:  Martin Zeidler; Alison Green
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

3.  Creutzfeldt-Jakob disease in Mexico.

Authors:  Leora Velásquez-Pérez; Daniel Rembao-Bojorquez; Jorge Guevara; Rosa María Guadarrama-Torres; Araceli Trejo-Contreras
Journal:  Neuropathology       Date:  2007-10       Impact factor: 1.906

4.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Pocchiari; S Collins; J P Brandel; J de Pedro Cuesta; R S Knight; H Bernheimer; F Cardone; N Delasnerie-Lauprêtre; N Cuadrado Corrales; A Ladogana; M Bodemer; A Fletcher; T Awan; A Ruiz Bremón; H Budka; J L Laplanche; R G Will; S Poser
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

5.  [Creutzfeldt-Jakob disease. Clinical, electrophysiological and histopathological correlations].

Authors:  M Martínez Barros; J Ramos Peek; R Vega; A Escobar
Journal:  Gac Med Mex       Date:  1995 Sep-Dec       Impact factor: 0.302

6.  Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease.

Authors:  A Schröter; I Zerr; K Henkel; H J Tschampa; M Finkenstaedt; S Poser
Journal:  Arch Neurol       Date:  2000-12

Review 7.  EEG in Creutzfeldt-Jakob disease.

Authors:  Heinz Gregor Wieser; Kaspar Schindler; Dominik Zumsteg
Journal:  Clin Neurophysiol       Date:  2006-01-25       Impact factor: 3.708

Review 8.  Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease.

Authors:  Y Shiga; K Miyazawa; S Sato; R Fukushima; S Shibuya; Y Sato; H Konno; K Doh-ura; S Mugikura; H Tamura; S Higano; S Takahashi; Y Itoyama
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

Review 9.  Risk management of the transmissible spongiform encephalopathies in North America.

Authors:  J A Kellar; V W Lees
Journal:  Rev Sci Tech       Date:  2003-04       Impact factor: 1.181

  9 in total
  1 in total

1.  A study of clinical profile, radiological and electroencephalographic characteristics of suspected Creutzfeldt-Jakob disease in a tertiary care centre in South India.

Authors:  Rohan R Mahale; Mahendra Javali; Anish Mehta; Suryanarayana Sharma; Purushottam Acharya; Rangasetty Srinivasa
Journal:  J Neurosci Rural Pract       Date:  2015-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.